Article Text

PDF
Recent advances in understanding the molecular basis of Paget disease of bone
  1. A Goode,
  2. R Layfield
  1. School of Biomedical Sciences, University of Nottingham Medical School, Queen's Medical Centre, Nottingham, UK
  1. Correspondence to Robert Layfield, School of Biomedical Sciences, University of Nottingham Medical School, Queen's Medical Centre, Nottingham NG7 2UH, UK; robert.layfield{at}nottingham.ac.uk

Abstract

Paget disease of bone (PDB) is a relatively common disorder characterised by increased bone turnover within discrete lesions throughout the skeleton. The condition has a strong genetic component, with mutations affecting the SQSTM1 gene that encodes the p62 protein often found in PDB patients, although environmental factors also play an important role in disease aetiology. The precise disease mechanism(s) in familial forms and sporadic forms of PDB is unclear, although defective RANK-NF-κB signalling has been suggested to contribute to the increased activity of pagetic osteoclasts in the former. Here, there is a review of recent advances in the understanding of the molecular basis of PDB with particular emphasis on findings since 2008, and focus on newly defined functions of the p62 protein upon which SQSTM1 mutations may impact in the development of the pagetic phenotype.

  • Paget disease
  • bone
  • SQSTM1
  • ubiquitin
  • NF-κB
  • autophagy

Statistics from Altmetric.com

Footnotes

  • Funding The work in the authors' laboratory is supported by the Paget's Association (National Association for the Relief of Paget's Disease) and the Arthritis Research Campaign.

  • Competing interests None.

  • Provenance and peer review Commissioned; not externally peer reviewed.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.